Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivativesVILLA, Pia; VAN BEEK, Johan; KIRSTINE LARSEN, Anna et al.Journal of cerebral blood flow and metabolism. 2007, Vol 27, Num 3, pp 552-563, issn 0271-678X, 12 p.Article

Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3NIELSEN, Mette; NISSEN, Mogens H; GERWIEN, Jens et al.Blood. 2002, Vol 99, Num 3, pp 973-977, issn 0006-4971Article

High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)KIRKEBY, Agnete; TORUP, Lars; BOCHSEN, Louise et al.Thrombosis and haemostasis. 2008, Vol 99, Num 4, pp 720-728, issn 0340-6245, 9 p.Article

Derivatives of erythropoietin that are tissue protective but not erythropoieticLEIST, Marcel; GHEZZI, Pietro; KALLUNKI, Pekka et al.Science (Washington, D.C.). 2004, Vol 305, Num 5681, pp 239-242, issn 0036-8075, 4 p.Article

The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietinXIAOYANG WANG; CHANGLIAN ZHU; XINHUA WANG et al.Journal of neurochemistry. 2004, Vol 91, Num 4, pp 900-910, issn 0022-3042, 11 p.Article